Loading…
Chembond Chemicals (CHEMBONDCH)₹222.44−3.56%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Chembond Chemicals reported sales of ₹95.68 Cr, up 31.3% from Sep 2025, and net profit of ₹3.25 Cr, down 54.7% year on year. For the year to Mar 2026, sales were ₹325 Cr and net profit ₹34.84 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 64.28 | 74.92 | 74.78 | 77.84 | 65.25 | 72.88 | 86.22 | 101 | 86.39 | 95.68 |
| Expenses | 57.02 | 67.19 | 60.52 | 65.77 | 56.97 | 62.36 | 74.03 | 85.53 | 75.18 | 87.47 |
| Operating Profit | 7.34 | 7.92 | 14.42 | 12.29 | 8.43 | 10.69 | 12.37 | 15.89 | 11.35 | 8.35 |
| OPM % | 11.4% | 10.5% | 19.2% | 15.7% | 12.8% | 14.6% | 14.3% | 15.7% | 13.1% | 8.7% |
| Other Income | 1.92 | 1.86 | 0.20 | 1.92 | 2.73 | 0.42 | 1.06 | −0.20 | 2.79 | 0.10 |
| Interest | 0.17 | 0.17 | 0.25 | 0.12 | 0.16 | 0.16 | 0.18 | 0.22 | 0.16 | 0.18 |
| Depreciation | 1.03 | 0.51 | 0.94 | 2.44 | 1.20 | 1.31 | 1.30 | 1.54 | 1.19 | 1.26 |
| Profit before tax | 8.04 | 9.06 | 13.39 | 11.60 | 9.78 | 9.60 | 11.90 | 13.92 | 12.75 | 6.99 |
| Tax % | 30.7% | 24.1% | 25.7% | 25.1% | 36.1% | 25.2% | 18.6% | 16.7% | 25.3% | 53.5% |
| Net Profit | 5.57 | 6.86 | 9.93 | 8.65 | 6.25 | 7.17 | 9.68 | 11.57 | 9.51 | 3.25 |
| EPS (Rs) | — | — | — | — | 2.34 | 2.71 | 3.63 | 4.37 | 3.55 | 1.22 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 349 | 440 | 283 | 291 | 325 | 369 |
| Expenses | 332 | 406 | 241 | 250 | 279 | 322 |
| Operating Profit | 17.01 | 35.01 | 42.07 | 42.05 | 48.04 | 47.96 |
| OPM % | 4.9% | 8.0% | 15.0% | 14.0% | 15.0% | 13.0% |
| Other Income | 9.01 | 5.01 | 4.01 | 6.01 | 4.01 | 3.75 |
| Interest | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.74 |
| Depreciation | 4.01 | 5.01 | 2.99 | 4.99 | 5.01 | 5.29 |
| Profit before tax | 20.97 | 33.95 | 41.88 | 41.93 | 44.92 | 45.56 |
| Tax % | 32.0% | 26.0% | 29.0% | 27.0% | 23.0% | — |
| Exceptional items | 0.00 | −0.02 | 0.43 | 0.86 | 1.13 | — |
| Net Profit | 13.94 | 24.89 | 29.86 | 30.87 | 34.84 | 34.01 |
| EPS (Rs) | — | — | — | — | 13.03 | 12.77 |
| Dividend payout % | 48.0% | 16.1% | 0.0% | 11.1% | 10.1% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 6.99 | 6.99 | 12.96 | 12.97 | 12.96 |
| Reserves | 297 | 315 | 130 | 161 | 194 |
| Borrowings | 1.99 | 6.98 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 55.73 | 72.65 | 36.82 | 39.81 | 44.78 |
| Total Liabilities | 360 | 402 | 180 | 214 | 251 |
| Fixed Assets | 121 | 117 | 21.95 | 20.97 | 22.96 |
| CWIP | 1.01 | 12.01 | 0.00 | 0.00 | 0.00 |
| Investments | 75.13 | 65.16 | 27.04 | 35.05 | 30.04 |
| Other Assets | 163 | 206 | 131 | 157 | 198 |
| Inventories | 34.14 | 34.12 | 17.05 | 18.08 | 23.07 |
| Trade receivables | 89.67 | 115 | 76.70 | 99.70 | 114 |
| Cash & equivalents | 18.95 | 20.94 | 26.93 | 25.94 | 35.89 |
| Total Assets | 360 | 402 | 180 | 214 | 251 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | — | −10.04 | 2.01 | −56.23 | 10.04 | 8.04 |
| Cash from investing activity | — | −2.01 | 0.00 | 48.03 | −9.01 | 1.01 |
| Cash from financing activity | — | −3.99 | −1.99 | 12.99 | −0.99 | −3.99 |
| Net cash flow | — | −15.99 | 0.00 | 5.99 | 0.99 | 4.99 |
| Capex | 4.38 | 4.29 | 14.67 | 19.85 | 4.59 | 6.93 |
| Free cash flow | — | −13.96 | −9.97 | −74.81 | 4.98 | 0.99 |
| CFO / OP % | — | −17.0% | 27.0% | −105.0% | 50.0% | 46.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 93 | 94 | 98 | 124 | 127 |
| Inventory days | 65 | 51 | 48 | 48 | 56 |
| Days payable | 75 | 80 | 76 | 72 | 74 |
| Cash conversion cycle | 83 | 66 | 71 | 101 | 108 |
| Working capital days | 78 | 70 | 80 | 104 | 120 |
| ROCE % | — | 11.0% | 18.1% | 26.1% | 24.0% |
For the Sep 2026 quarter, Chembond Chemicals reported sales of ₹95.68 Cr, up 31.3% year on year and net profit of ₹3.25 Cr, down 54.7% year on year. The operating margin was 8.7%.
Chembond Chemicals' sales for the year to Mar 2026 were ₹325 Cr; over the last twelve months they were ₹369 Cr.
Net profit for the year to Mar 2026 was ₹34.84 Cr, and ₹34.01 Cr over the last twelve months. Earnings per share over the same trailing period were ₹12.77.
Chembond Chemicals reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹35.89 Cr.
Cash from operations was ₹8.04 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.99 Cr.